Recall of RENIN III GENERATION

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by BIO-RAD LABORATORIES (CANADA) LTD..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    88554
  • Event Risk Class
    II
  • Event Initiated Date
    2017-08-02
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Bio-rad laboratories (canada) ltd emet ce rappel suite a une erreur fortuite qui s'est produite le 24 juillet dernier lors de la reception et de l'attribution des stocks de produits au centre de distribution de mississauga. la performance des trousses contenues dans cet envoi a ete compromise a cause des conditions d'entreposage inadequates pendant le transfert.

Device

  • Model / Serial
    Model Catalog: RENINE (Lot serial: 193A); Model Catalog: THYRO (Lot serial: 195A); Model Catalog: ELSA-ACTH (Lot serial: 373A); Model Catalog: HGH-RIACT (Lot serial: 212A); Model Catalog: IRMA-HCT (Lot serial: 392A)
  • Product Description
    RENIN III GENERATION;THYROGLOBULINE IRMA;ELSA-ACTH;HGH-RIACT (HUMAN GROWTH HORMONE);CALCITONINE IRMA-HCT
  • Manufacturer

Manufacturer